SB174 Alabama 2020 Session

Summary

Primary Sponsor

Sam GivhanSenator

Republican

Session

Regular Session 2020

Title

Controlled substances, relating to Schedule II, adding certain named chemical compounds of Tianeptine, Sec. 20-2-25 am'd.

Summary

SB 174 would add Tianeptine and related compounds to Schedule II, making possession and distribution illegal and enabling potential future medical use if approved.

What This Bill Does

It adds Tianeptine and related salts, derivatives, and closely related compounds to Schedule II of Alabama's controlled substances list, making possession, distribution, and trafficking illegal with penalties for distribution. It also states that placing Tianeptine on Schedule II could allow for future medical prescription if FDA approves its use in humans. The bill also includes a clause saying it is exempt from local-funding requirements under Amendment 621 because it defines a new crime (or amends an existing crime).

Who It Affects

• Individuals who possess, distribute, or traffic Tianeptine compounds would face criminal penalties under the new Schedule II designation.
• Law enforcement, prosecutors, and health regulators would enforce the new rules and manage any potential future prescription pathway if FDA approval occurs.

Key Provisions

• Adds Tianeptine and related salts, derivatives, and preparations to Schedule II in Section 20-2-25, making possession, distribution, and trafficking illegal with penalties for distribution.
• Provides that the bill is exempt from Amendment 621 local-funding requirements because it creates a new crime or amends the definition of an existing crime.

AI-generated summary using openai/gpt-5-nano on Feb 23, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances